However, both GLP-1 and GIP are quickly degraded by dipeptidyl peptidase 4 (DPP-4) enzyme (Figure 1)
Phase 2 trials - secondary measures Phase 3 results (pending) TRIUMPH and TRANSCEND are the large Phase 3 programmes asking the longer-term safety and outcome questions
Required documentation typically includes the prescription, two years of relevant medical records, prior weight-loss attempt history, lab values (lipid panel, A1c, CMP), and any comorbidity workup (sleep study for OSA indication, CV imaging for SELECT indication)
This guide covers the complete physiology behind GLP-1 weight loss stalls across every major medication, from semaglutide to tirzepatide to retatrutide
The changing faces of glutathione, a cellular protagonist
My skin stays fresh and bright all day